Programs and Services » Accreditation/Quality of Care » Alberta Laboratory Quality Enhancement Program » Transfusion Medicine » Survey Reports

Transfusion Medicine

Survey Reports

By survey year/challenge identification number

Expand all

2011		2010
11-11 & 11-12		10-11 & 10-12
11-09 & 11-10		10-09 & 10-10
11-07 & 11-08		10-07 & 10-08
11-05 & 11-06		10-05 & 10-06
11-03 & 11-04		10-03 & 10-04
11-01 & 11-02		10-01 & 10-02

2009		2008
09-11 & 09-12		08-11 & 08-12
09-09 & 09-10		08-09 & 08-10
09-07 & 09-08		08-07 & 08-08
09-05 & 09-06		08-05 & 08-06
09-03 & 09-04		08-03 & 08-04
09-01 & 09-02		08-01 & 08-02

2007		2006
07-11 & 07-12		06-11 & 06-12
07-09 & 07-10		06-09 & 06-10
07-07 & 07-08		06-07 & 06-08
07-05 & 07-06		06-05 & 06-06
07-03 & 07-04		06-03 & 06-04
07-01 & 07-02		06-01 & 06-02

2001

By feature listing/alphabetical sort

Expand all

A thru C

Survey	Description
11-09 A	ABO Typing Discrepancy
10-02 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
07-03 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
05-07 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
04-10 B	ABO Typing Discrepancy: absence of expected reverse typing reactions
03-12 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
02-12 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
01-05 A/B	ABO Typing Discrepancy: absence of expected reverse typing reactions
08-06 B	ABO Typing Discrepancy: bone marrow transplant patient
11-02 B	ABO Typing Discrepancy: lack of expected reverse typing reactions
05-09 A/B	Acute Hemolytic Transfusion Reaction
02-02 A/B	Anti-A1
11-09A	Anti-c
11-07 A	Anti-c
10-11 A	Anti-c
04-02 A	Anti-Cw
03-01 B	Anti-Cw
11-04 A	Anti-D + Anti-C
12-04 A	Anti-D + Anti-C
11-04 B	Anti-D
11-12 B	Anti-D
12-04 B	Anti-D
11-09 B	Anti-e
02-10 A	Anti-e
11-06 A/B	Anti-E
10-11 B	Anti-E
11-12 A	Anti-Fy(a)
03-07 A	Anti-G
01-01 A	Anti-G
11-08 A/B	Anti-Jk(a)
11-01 A/B	Anti-Jk(a)
09-11 A/B	Anti-Jk(a)
09-10 A/B	Anti-Jk(a)
10-08 A/B	Anti-Jk(a) exhibiting dosage effect
11-05 B	Anti-K
11-02 A	Anti-K
01-08 B	Anti-M
11-05 A	Anti-s
09-07 A	Anti-s
03-08 A	Anti-s
10-03 A	Anti-s in s positive patient

Contact

Liz McBride, Program Manager, Laboratory Accreditation Services
780-969-5010 or 1-800-561-3899 ext. 5010 (Alberta only)
Liz.McBride@cpsa.ab.ca

Bev Padget, ALQEP Transfusion Medicine Proficiency Program Coordinator
780-431-8719
Bev.padget@blood.ca

Eve Behr, ALQEP Technical Analyst
780-969-5011 or 1-800-561-3899 ext. 5011 (Alberta only)
Eve.Behr@cpsa.ab.ca

2013		2012
		12-01 & 12-02
		12-03 A/B
		12-04 A
		12 -04

2005		2004
05-11 & 05-12		04-11 & 04-12
05-09 & 05-10		04-09 & 04-10
05-07 & 05-08		04-07 & 04-08
05-05 & 05-06		04-05 & 04-06
05-03 & 05-04		04-03 & 04-04
05-01 & 05-02		04-01 & 04-02

2003		2002
03-11 & 03-12		02-11 & 02-12
03-09 & 03-10		02-09 & 02-10
03-07 & 03-08		02-07 & 02-08
03-05 & 03-06		02-05 & 02-06
03-03 & 03-04		02-03 & 02-04
03-01 & 03-02		02-01 & 02-02

Survey	Description
09-09 A/B	Direct Antiglobulin Test
08-09 A/B	Direct Antiglobulin Test
07-09 A/B	Direct Antiglobulin Test
06-09 A/B	Direct Antiglobulin Test
05-06 A/B	Direct Antiglobulin Test
04-09 A/B	Direct Antiglobulin Test
03-09 A/B	Direct Antiglobulin Test
02-06 A/B	Direct Antiglobulin Test
12-03 A/B	Gel crossmatch limitations
09-07 B -08 B	Immediate spin crossmatch validity
06-11 B	Immediate spin crossmatch validity
06-06 B	Immediate spin crossmatch validity
06-03 B	Immediate spin crossmatch validity
03-01 B	Immediate spin crossmatch validity

Survey	Description
12-02 A/B	Mislabeled Samples
11-10 A/B	Mislabeled Samples
10-05 A/B	Mislabeled Samples
09-04 A/B	Mislabeled Samples
08-03 A/B	Mislabeled Samples
07-06 A/B	Mislabeled Samples
06-05 A/B	Mislabeled Samples
05-10 A/B	Mislabeled Samples
04-07 A/B	Mislabeled Samples
03-05 A/B	Mislabeled Samples
02-04 A/B	Mislabeled Samples
01-03 A/B	Mislabeled Samples
08-12 A/B	Mixed Field Agglutination
07-12 B	Mixed Field Agglutination
06-07 A/B	Mixed Field Agglutination
05-01 A/B	Mixed Field Agglutination
04-04 A/B	Mixed Field Agglutination
02-08 A/B	Mixed Field Agglutination
01-12 A/B	Mixed Field Agglutination
01-02 A/B	Mixed Field Agglutination

Transfusion Medicine

Survey Reports

2013 - 2012

2011 - 2010

2009 - 2008

2007 - 2006

2005 - 2004

2003 - 2002

2001

A thru C

D thru L

M

N thru Z

Contact

Survey	Description
11-03 A/B	Non-reactive historical antibody
10-04 A/B	Non-reactive historical antibody
09-08 A/B	Non-reactive historical antibody
06-03 A/B	Non-reactive historical antibody
05-03 A/B	Non-reactive historical antibody
10-04 A	Phenotyping – recently transfused patient
09-10 A/B	Phenotyping – recently transfused patient
07-12 A	Phenotyping – recently transfused patient
04-01 A/B	Phenotyping – recently transfused patient
02-01 A	Phenotyping – recently transfused patient
04-11 A/B	Postnatal Testing
11-08 A/B	Rh(D) Typing – AB D Positive patient control
10-12 A/B	Rh(D) Typing – AB D Positive patient control
09-06 A/B	Rh(D) Typing – AB D Positive patient control
08-08 B	Rh(D) Typing – AB D Positive patient control
07-07 A/B	Rh(D) Typing – AB D Positive patient control
04-06 A/B	Rh(D) Typing – AB D Positive patient control
03-03 A/B	Rh(D) Typing - discrepancy due to spontaneous agglutination
08-10 A	Rh(D) Typing – variable results
07-07 A/B	Rh(D) Typing – variable results
11-12 A/B	Uncomplicated case